The Latin America, Middle East and Africa Cytosine Market would witness market growth of 12.4% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 156.53 Tonnes, showcasing a growth of 11.7% (2023-2030).
The increasing focus on biopharmaceutical research and development, especially in personalized medicine and targeted therapies, fuels the demand for this compound and its derivatives. These compounds play a crucial role in the development of next-generation drugs. Government initiatives to support biotechnology and genomics research and regulatory frameworks for developing genetically modified organisms influence the market.
The need for sustainable agriculture to meet the demands of a growing population is pushing the boundaries of genetic engineering in crops. Cytosine's role in creating genetically modified crops with enhanced traits contributes to addressing food security concerns. Collaborations between academic institutions, research organizations, and biotechnology companies contribute to the expansion of the market. These partnerships often focus on joint research initiatives, sharing expertise, and leveraging resources for product development.
Over AED 21 billion was invested in the chemical industry in 2021, according to the Industrial Development Bureau of the United Arab Emirates (UAE). This indicates that the chemical industry in Abu Dhabi is the most significant contributor to the city's gross domestic product (GDP), accounting for 53% of the total in 2021. The UAE's strategic positioning as a global business hub could attract companies involved in chemical and biotechnological research. This could lead to an increased presence of businesses that use this compound in their processes. The chemical industry in the UAE, with a focus on life sciences and healthcare applications, may contribute to the demand for this compound. As a result, these aspects will boost the market growth in the coming years.
The Brazil market dominated the LAMEA Cytosine Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $14.6 million by 2030. The Argentina market is showcasing a CAGR of 13% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.8% during (2023 - 2030).
Based on End-use, the market is segmented into Pharmaceutical, Agriculture, Chemical Industry, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The increasing focus on biopharmaceutical research and development, especially in personalized medicine and targeted therapies, fuels the demand for this compound and its derivatives. These compounds play a crucial role in the development of next-generation drugs. Government initiatives to support biotechnology and genomics research and regulatory frameworks for developing genetically modified organisms influence the market.
The need for sustainable agriculture to meet the demands of a growing population is pushing the boundaries of genetic engineering in crops. Cytosine's role in creating genetically modified crops with enhanced traits contributes to addressing food security concerns. Collaborations between academic institutions, research organizations, and biotechnology companies contribute to the expansion of the market. These partnerships often focus on joint research initiatives, sharing expertise, and leveraging resources for product development.
Over AED 21 billion was invested in the chemical industry in 2021, according to the Industrial Development Bureau of the United Arab Emirates (UAE). This indicates that the chemical industry in Abu Dhabi is the most significant contributor to the city's gross domestic product (GDP), accounting for 53% of the total in 2021. The UAE's strategic positioning as a global business hub could attract companies involved in chemical and biotechnological research. This could lead to an increased presence of businesses that use this compound in their processes. The chemical industry in the UAE, with a focus on life sciences and healthcare applications, may contribute to the demand for this compound. As a result, these aspects will boost the market growth in the coming years.
The Brazil market dominated the LAMEA Cytosine Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $14.6 million by 2030. The Argentina market is showcasing a CAGR of 13% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.8% during (2023 - 2030).
Based on End-use, the market is segmented into Pharmaceutical, Agriculture, Chemical Industry, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
- VIVAN Life Sciences Pvt. Limited
- Tokyo Chemical Industry Co. Ltd.
- Santa Cruz Biotechnology, Inc.
- FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
- Central Drug House (P) Ltd.
- Naugra Export
- Marine Chemical
Market Report Segmentation
By End-use (Volume, Tonnes, USD Million, 2019-2030)- Pharmaceutical
- Agriculture
- Chemical Industry
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Cytosine Market, By End-use
Chapter 5. LAMEA Cytosine Market, By Country
Chapter 6. Company Profiles
Companies Mentioned
- Spectrum Chemical Mfg. Corp (Spectrum Laboratory Products, Inc.)
- VIVAN Life Sciences Pvt. Limited
- Tokyo Chemical Industry Co. Ltd.
- Santa Cruz Biotechnology, Inc.
- FUJIFILM Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
- Central Drug House (P) Ltd.
- Naugra Export
- Marine Chemical
Methodology
LOADING...
